EGFR-targeted and MMP-activated membranolytic peptides kill cancer cells specifically in vitro and reduce tumour growth in vivo

Pramanik, Arindam, Booth, Andrew, Kobza, Dagmara et al. (4 more authors) (Accepted: 2026) EGFR-targeted and MMP-activated membranolytic peptides kill cancer cells specifically in vitro and reduce tumour growth in vivo. MOLECULAR PHARMACEUTICS. ISSN: 1543-8384 (In Press)

Metadata

Item Type: Article
Authors/Creators:
Dates:
  • Accepted: 27 March 2026
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Biology (York)
The University of York > Faculty of Sciences (York) > Biology (York) > Jack Birch Unit for Molecular Carcinogenesis (York)
Funding Information:
Funder
Grant number
EPSRC
EP/R03608X/1
Date Deposited: 02 Apr 2026 16:10
Last Modified: 02 Apr 2026 16:10
Status: In Press
Refereed: Yes
Open Archives Initiative ID (OAI ID):

Download

Accepted Version


Under temporary embargo

Filename: Pramanik_et_al_R3.pdf

Description: Pramanik et al R3

Licence: CC-BY 2.5

Request a copy

file not available

Export

Statistics


CORE (COnnecting REpositories)